Front Matter
Total Page:16
File Type:pdf, Size:1020Kb
ANTICANCER RESEARCH International Journal of Cancer Research and Treatment ISSN: 0250-7005 Volume 29, Number 1, January 2009 Experimental Studies Contents Bortezomib Therapeutic Effect is Associated with Expression of FGFR3 in Multiple Myeloma Cells. M. GUAN, L. ZHU, G. SOMLO, A. HUGHES, B. ZHOU, Y. YEN (Duarte, CA, USA; Zhejiang, China)........... 1 Utilization of a Right-handed Coiled-coil Protein from Archaebacterium Staphylothermus marinus as a Carrier for Cisplatin. M. ERIKSSON, S. HASSAN, R. LARSSON, S. LINDER, T. RAMQVIST, H. LÖVBORG, T. VIKINGE, E. FIGGEMEIER, J. MÜLLER, J. STETEFELD, T. DALIANIS, S. ÖZBEK (Stockholm; Uppsala; Linköping, Sweden; Basel, Switzerland; Winnipeg, Manitoba, Canada; Heidelberg, Germany)............................. 11 Gene Amplification of Myc and its Coamplification with ERBB2 and EGFR in Gallbladder Adenocarcinoma. A. OOI, S. SUZUKI, K. NAKAZAWA, J. ITAKURA, I. IMOTO, H. NAKAMURA, Y. DOBASHI (Ιshikawa; Yamanishi; Tokyo; Saitama, Japan) ........................................................................................................................ 19 Effect of Verapamil on the Expression of EGFR and NM23 in A549 Human Lung Cancer Cells. C. ZHANG, F. LV, L. ZHOU, X. LI, X.-X. WU, R.M. HOFFMAN (Harbin; Qiqihaer, China; Kagawa, Japan; San Diego, CA, USA) ................................................................................................................................................................. 27 Antioxidant Effects of Quercetin and Coenzyme Q10 in Mini Organ Cultures of Human Nasal Mucosa Cells. M. REITER, K. RUPP, P. BAUMEISTER, S. ZIEGER, U. HARRÉUS (Munich, Germany) ........................... 33 Distinct Patient Responses to Activation of T-cells by Free HER-2, G89 (777-789) and Protected LRMK-linked HER-2, {AE-39 [p776 (Ava-774-788)], AE-47 [(Ava-776-788)] and AE-37[p776 (774-788)]} Peptides Could Lead to Development of Personalized Cancer Vaccines. Y. LI, S. MATSUEDA, C.L. EFFERSON, N. TSUDA, K. KAWANO, H. GAO, G.E. PEOPLES, C.G. IOANNIDES (Houston; San Antonio, TX, USA) ................................ 41 Contents continued on the back cover ANTICANCER RESEARCH International Journal of Cancer Research and Treatment ISSN: 0250-7005 Editorial Board Editorial Office: International Institute of Anticancer Research, 1st km Kapandritiou-Kalamou Rd., Kapandriti, P.O. Box 22, Attiki 19014, B. B. AGGARWAL, Houston, TX, USA G. R. F. KRUEGER, Köln, Germany Greece. Tel / Fax: +30-22950-53389. J. P. ARMAND, Villejuif, France D. W. KUFE, Boston, MA, USA E-mails: Editorial Office: [email protected] D. ASSIMAKOPOULOS, loannina, Greece Pat KUMAR, Manchester, UK Managing Editor: [email protected] V. I. AVRAMIS, Los Angeles, CA, USA Shant KUMAR, Manchester, UK ANTICANCER RESEARCH supports: (a) the establishment and the R. C. BAST, Houston, TX, USA M. KUROKI, Fukuoka, Japan activities of the INTERNATIONAL INSTITUTE OF ANTICANCER G. BAUER, Freiburg, Germany O. D. LAERUM, Bergen, Norway RESEARCH (IIAR; Kapandriti, Attiki, Greece); and (b) the organization E. E. BAULIEU, Le Kremlin-Bicetre, France F. J. LEJEUNE, Lausanne, Switzerland of the International Conferences of Anticancer Research. Y. BECKER, Jerusalem, Israel C. J. LINK, Clive, IA, USA For more information about ANTICANCER RESEARCH, IIAR and the E. J. BENZ , Jr., Boston, MA, USA L. A. LIOTTA, Manassas, VA, USA Conferences, please visit the IIAR website: www.iiar-anticancer.org J. BERGH, Stockholm, Sweden L. F. LIU, Piscataway, NJ, USA Publication Data: ANTICANCER RESEARCH (AR) is published monthly J. L. BIEDLER, Bronx, NY, USA D. M. LOPEZ, Miami, FL, USA from January 2009. Each annual volume comprises 12 issues. Annual D. D. BIGNER, Durham, NC, USA E. LUNDGREN, Ume Æa, Sweden Author and Subject Indices are included in the last issue of each volume. A. BÖCKING, Düsseldorf, Germany H. T. LYNCH, Omaha, NE, USA ANTICANCER RESEARCH Vol. 24 (2004) and onwards will appear online G. BONADONNA, Milan, Italy J. MARESCAUX, Strasbourg, France with Stanford University HighWire Press from April 2009. F. T. BOSMAN, Lausanne, Switzerland J. MARK, Skövde, Sweden Copyright: On publication of a manuscript in AR, which is a G. BROICH, Lodi, Italy J. F. MARSHALL, London, UK copyrighted publication, the legal ownership of all published parts of J. M. BROWN, Stanford, CA, USA D. MEDINA, Houston, TX, USA the paper passes from the Author(s) to the Journal. Ø. S. BRULAND, Oslo, Norway S. MITRA, Galveston, TX, USA Annual Subscription Rates 2009 per volume: Institutional subscription M. M. BURGER, Basel, Switzerland F. M. MUGGIA, New York, NY, USA Euro 1,612.00 - online; Euro 1,634.00 - print; Euro 1,682.00 - print & M. CARBONE, Honolulu, HI, USA M. J. MURPHY, Jr., Dayton, OH, USA online. Personal subscription Euro 763.00 - online; Euro 785.00 - print; J. CARLSSON, Uppsala, Sweden R. NARAYANAN, Boca Raton, FL, USA Euro 833 - print & online. Prices include rapid delivery and insurance. A. F. CHAMBERS, London, ON, Canada K. NILSSON, Uppsala, Sweden The complete previous volumes of Anticancer Research (Vol. 1-28, 1981- P. CHANDRA, Frankfurt am Main, Germany J. F. NOVAK, Lewisburg, PA, USA 2008) are available at 50% discount on the above rates. L. CHENG, Indianapolis, IN, USA S. PATHAK, Houston, TX, USA Subscription Orders: Orders can be placed at agencies, bookstores, or J.-G. CHUNG , Taichung, Taiwan, ROC S. PESTKA, Piscataway, NJ, USA directly with the Publisher. Cheques should be made payable to J.G. E. DE CLERCQ, Leuven, Belgium G. J. PILKINGTON, Portsmouth, UK Delinassios, Executive Publisher of Anticancer Research, Athens, Greece, W. DE LOECKER, Leuven, Belgium C. D. PLATSOUCAS, Norfolk, VA, USA and should be sent to the Editorial Office. W. DEN OTTER, Amsterdam , The Netherlands F. PODO, Rome, Italy Advertising: All correspondence and rate requests should be E. P. DIAMANDIS, Toronto, ON, Canada A. POLLIACK, Jerusalem, Israel addressed to the Editorial Office. G. TH. DIAMANDOPOULOS, Boston, MA, USA M. F. RAJEWSKY, Essen, Germany Book Reviews: Recently published books and journals should be sent to W. EBERT, Heidelberg, Germany G. REBEL, Strasbourg, France the Editorial Office. Reviews will be published within 2-4 months. U. EPPENBERGER, Basel, Switzerland M. RIGAUD, Limoges, France Articles in ANTICANCER RESEARCH are regularly indexed in all J. A. FERNANDEZ-POL, Chesterfield, MO, USA U. RINGBORG, Stockholm, Sweden bibliographic services, including Current Contents (Life Sciences), Science I. J. FIDLER, Houston, TX, USA M. ROSELLI, Rome, Italy Citation Index, Index Medicus, Biological Abstracts, PubMed, Chemical W. FIERS, Ghent, Belgium A. SCHAUER, Göttingen, Germany Abstracts, Excerpta Medica, University of Sheffield Biomedical Information Service, Current Clinical Cancer, AIDS Abstracts, Elsevier Bibliographic N. E. FUSENIG, Heidelberg, Germany M. SCHNEIDER, Wuppertal, Germany Database, EMBASE, Compendex, GEOBASE, EMBiology, Elsevier BIOBASE, G. GABBIANI, Geneva, Switzerland A. SETH, Toronto, ON, Canada FLUIDEX, World Textiles, Scopus, Progress in Palliative Care, Cambridge A. F. GAZDAR, Dallas, TX, USA G. V. SHERBET, Newcastle-upon-Tyne, UK Scientific Abstracts, Cancergram (International Cancer Research Data A. GIORDANO, Philadelphia, PA, USA G.-I. SOMA, Tokushima, Japan Bank), MEDLINE, Reference Update - RIS Inc., PASCAL-CNRS, Inpharma- G. GITSCH, Freiburg, Germany G. S. STEIN, Worcester, MA, USA Reactions (Datastar, BRS), CABS, Immunology Abstracts, Telegen Abstracts, R. H. GOLDFARB, Princeton, NJ, USA T. STIGBRAND, Ume aÆ, Sweden Genetics Abstracts, Nutrition Research Newsletter, Dairy Science Abstracts, J. W. GORROD, Colchester, Essex, UK K. TAKAGI, Kumamoto, Japan Current Titles in Dentistry, Inpharma Weekly, BioBase, MedBase, CAB S. HAMMARSTRÖM, Ume Æa, Sweden D. TARIN, La Jolla, CA, USA Abstracts/Global Health Databases, Investigational Drugs Database, VINITI I. HART, London, UK G. B. de THÉ, Paris, France Abstracts Journal, Leeds Medical Information, PubsHub, Sociedad I. HELLSTRÖM, Seattle, WA, USA T. M. THEOPHANIDES, Athens, Greece Iberoamericana de Informaci ón Cient ífíca (SIIC) Data Bases. L. HELSON, Valhalla, NY, USA B. TOTH, Omaha, NE, USA Authorization to photocopy items for internal or personal use, or the R. B. HERBERMAN, Pittsburgh, PA, USA E. TRELL, Linköping, Sweden internal or personal clients, is granted by ANTICANCER RESEARCH, R. M. HOFFMAN, San Diego, CA, USA P. M. UELAND, Bergen, Norway provided that the base fee of $2.00 per copy, plus 0.40 per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, C. G. IOANNIDES, Houston, TX, USA P. T. VIHKO, Oulu, Finland MA 01970, USA. For those organizations that have been granted a S. C. JHANWAR, New York, NY, USA M. VOLM, Heidelberg, Germany photocopy license by CCC, a separate system of payment has been J. V. JOHANNESSEN, Oslo, Norway G. WEBER, Indianapolis, IN, USA arranged. The fee code for users of the Transactional Reporting Service is B. KAINA, Mainz, Germany I. B. WEINSTEIN, New York, NY, USA 0250-7005/2009 $2.00 +0.40. B. K. KEPPLER, Vienna, Austria B. WESTERMARK, Uppsala, Sweden The Editors and Publishers of ANTICANCER RESEARCH accept no D. G. KIEBACK , Dresden, Germany B. ZUMOFF, New York, NY, USA responsibility for the opinions expressed by the contributors or for the J. KIELER, Copenhagen, Denmark content of advertisements appearing therein. R. KLAPDOR, Hamburg, Germany J. G. DELINASSIOS, Athens, Greece U. R. KLEEBERG, Hamburg, Germany Managing Editor and Executive Publisher Copyright© 2009, πnternational Institute